Bookmark and Share

BioActivity Data for Gene MBD2 (Gene ID:8932)

Also known as: DMTase, NY-CO-41.
BioActivity Outcomes:
Active(1446)
 
 
Inactive(369963)
 
 
Unspecified(2)
 
 
BioAssay Types:
Screening(371317)
 
 
 
Confirmatory(83)
 
 
 
Literature(9)
 
 
BioAssay Categories:
Biochemical(371395)
 
 
 
Toxicity(3)
 
 
BioActivity Types:
IC50(83)
 
 
 
Substance Types:
Chemical(371395)
 
 
 
RNAi(16)
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 12    Data Row: 371411   Total Pages: 18571   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID26661173]
[CID1872967]
IC50 0.988TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID720645, Type: confirmatory] [gi:21595776]
View
2
[SID165224820]
[CID60138096]
IC50 2.191Late stage TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID1053169, Type: confirmatory] [gi:21595776]
View
3
[SID92764840]
[CID386514]
IC50 3.249TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID720645, Type: confirmatory] [gi:21595776]
View
4
[SID165224834]
[CID386514]
IC50 3.354Late stage TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID1053169, Type: confirmatory] [gi:21595776]
View
5
[SID143471981]
[CID60138096]
IC50 4.073TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID720645, Type: confirmatory] [gi:21595776]
View
6
[SID165224812]
[CID285027]
IC50 4.179Late stage TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID1053169, Type: confirmatory] [gi:21595776]
View
7
[SID49736535]
[CID20923253]
IC50 4.409TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID720645, Type: confirmatory] [gi:21595776]
View
8
[SID47204251]
[CID235224]
IC50 4.695TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID720645, Type: confirmatory] [gi:21595776]
View
9
[SID24829570]
[CID16196160]
IC50 4.777TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID720645, Type: confirmatory] [gi:21595776]
View
10
[SID165224817]
[CID285026]
IC50 4.855Late stage TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID1053169, Type: confirmatory] [gi:21595776]
View
11
[SID26666086]
[CID3737083]
IC50 4.867TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID720645, Type: confirmatory] [gi:21595776]
View
12
[SID165224831]
[CID20923253]
IC50 5.071Late stage TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID1053169, Type: confirmatory] [gi:21595776]
View
13
[SID165224802]
[CID333459]
IC50 5.624Late stage TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID1053169, Type: confirmatory] [gi:21595776]
View
14
[SID143471982]
[CID60138097]
IC50 5.859TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID720645, Type: confirmatory] [gi:21595776]
View
15
[SID165224828]
[CID5412959]
IC50 5.89Late stage TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID1053169, Type: confirmatory] [gi:21595776]
View
16
[SID92763341]
[CID333459]
IC50 6.606TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID720645, Type: confirmatory] [gi:21595776]
View
17
[SID99356260]
[CID285027]
IC50 6.689TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID720645, Type: confirmatory] [gi:21595776]
View
18
[SID24784363]
[CID12477066]
IC50 6.92TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID720645, Type: confirmatory] [gi:21595776]
View
19
[SID26662576]
[CID188677]
IC50 7.006TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID720645, Type: confirmatory] [gi:21595776]
View
20
[SID165224800]
[CID386511]
IC50 7.396Late stage TRFRET-based biochemical high throughput dose response assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide [AID1053169, Type: confirmatory] [gi:21595776]
View